Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Accuracy of Preoperative Percutaneous Biopsy for the Diagnosis of Retroperitoneal Liposarcoma Subtypes.
[liposarcoma]
Surgery
is
the
primary
treatment
for
all
subtypes
of
retroperitoneal
liposarcoma
,
but
neoadjuvant
therapy
may
be
warranted
in
cases
of
dedifferentiated
liposarcoma
(
DDLS
)
,
which
has
an
increased
risk
of
recurrence
and
metastasis
.
Therefore
,
an
accurate
subtype-
specific
diagnosis
is
vital
for
appropriate
consideration
of
neoadjuvant
therapy
.
Previous
studies
assessing
the
subtype-
specific
accuracy
of
percutaneous
biopsy
are
limited
.
We
aimed
to
analyze
the
accuracy
of
preoperative
percutaneous
biopsy
in
the
subtype-
specific
diagnosis
of
retroperitoneal
liposarcoma
and
thus
the
reliability
of
percutaneous
biopsy
in
guiding
decisions
about
neoadjuvant
treatment
.
We
retrospectively
reviewed
the
medical
records
,
including
the
pathologic
reports
,
interventional
radiology
reports
,
and
operative
reports
,
of
patients
registered
in
the
retroperitoneal
/
well-differentiated
liposarcoma
(
WDLS
/
DDLS
)
database
at
The
University
of
Texas
MD
Anderson
Cancer
Center
between
1993
and
2013
.
We
identified
120
patients
who
underwent
137
preoperative
percutaneous
biopsies
followed
by
surgical
resections
.
Pathologic
examination
following
resection
indicated
that
74
of
the
patients
had
WDLS
and
63
had
DDLS
.
The
overall
diagnostic
accuracy
of
percutaneous
biopsy
for
identifying
the
subtype
of
liposarcoma
was
62
.
8
Â
%
(
86
/
137
)
;
the
accuracy
for
identifying
WDLS
was
significantly
higher
(
85
.
1
Â
%
;
63
/
74
)
than
that
for
identifying
DDLS
(
36
.
5
Â
%
;
23
/
63
)
(
p
Â
<
Â
0
.
01
)
.
Percutaneous
biopsy
has
low
accuracy
in
the
diagnosis
of
retroperitoneal
DDLS
.
This
can
potentially
mislead
physicians
in
the
decision
to
implement
neoadjuvant
treatment
.
When
developing
treatment
strategies
,
including
clinical
trials
for
patients
with
retroperitoneal
liposarcoma
,
physicians
should
carefully
consider
the
low
accuracy
of
percutaneous
biopsy
in
detecting
DDLS
.
Diseases
Validation
Diseases presenting
"cancer"
symptom
achondroplasia
acute rheumatic fever
adrenal incidentaloma
alpha-thalassemia
benign recurrent intrahepatic cholestasis
cadasil
canavan disease
carcinoma of the gallbladder
cholangiocarcinoma
coats disease
congenital adrenal hyperplasia
congenital diaphragmatic hernia
cowden syndrome
cushing syndrome
cutaneous mastocytosis
dedifferentiated liposarcoma
dystrophic epidermolysis bullosa
epidermolysis bullosa simplex
erdheim-chester disease
erythropoietic protoporphyria
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
familial hypocalciuric hypercalcemia
familial mediterranean fever
gm1 gangliosidosis
heparin-induced thrombocytopenia
hereditary cerebral hemorrhage with amyloidosis
hirschsprung disease
hodgkin lymphoma, classical
inclusion body myositis
junctional epidermolysis bullosa
kabuki syndrome
kallmann syndrome
kindler syndrome
lamellar ichthyosis
liposarcoma
locked-in syndrome
lymphangioleiomyomatosis
monosomy 21
neuralgic amyotrophy
oculocutaneous albinism
oligodontia
oral submucous fibrosis
papillon-lefèvre syndrome
pendred syndrome
pleomorphic liposarcoma
primary effusion lymphoma
proteus syndrome
pyomyositis
pyruvate dehydrogenase deficiency
severe combined immunodeficiency
sneddon syndrome
systemic capillary leak syndrome
triple a syndrome
von hippel-lindau disease
waldenström macroglobulinemia
well-differentiated liposarcoma
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
This symptom has already been validated